These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11089660)

  • 1. Reintroduction of influenza A to a nursing building.
    Drinka PJ; Gravenstein S; Krause P; Nest L; Dissing M; Shult P
    Infect Control Hosp Epidemiol; 2000 Nov; 21(11):732-5. PubMed ID: 11089660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outbreaks of influenza A and B in a highly immunized nursing home population.
    Drinka PJ; Gravenstein S; Krause P; Schilling M; Miller BA; Shult P
    J Fam Pract; 1997 Dec; 45(6):509-14. PubMed ID: 9420587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence and transmission of amantadine-resistant influenza A in a nursing home.
    Schilling M; Gravenstein S; Drinka P; Cox N; Krause P; Povinelli L; Shult P
    J Am Geriatr Soc; 2004 Dec; 52(12):2069-73. PubMed ID: 15571544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of antiviral prophylaxis during nursing home outbreaks of influenza A: a comparison of 2 protocols.
    Drinka PJ; Gravenstein S; Schilling M; Krause P; Miller BA; Shult P
    Arch Intern Med; 1998 Oct; 158(19):2155-9. PubMed ID: 9801184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using antiviral agents to control outbreaks of influenza A infection.
    Monto AS
    Geriatrics; 1994 Dec; 49(12):30-4. PubMed ID: 7982583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of an outbreak: nursing home architecture and influenza-A attack rates.
    Drinka PJ; Krause P; Schilling M; Miller BA; Shult P; Gravenstein S
    J Am Geriatr Soc; 1996 Aug; 44(8):910-3. PubMed ID: 8708299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delays in the application of outbreak control prophylaxis for influenza A in a nursing home.
    Drinka PJ; Krause P; Nest L; Gravenstein S; Goodman B; Shult P
    Infect Control Hosp Epidemiol; 2002 Oct; 23(10):600-3. PubMed ID: 12400890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zanamivir use during transmission of amantadine-resistant influenza A in a nursing home.
    Lee C; Loeb M; Phillips A; Nesbitt J; Smith K; Fearon M; McArthur MA; Mazzulli T; Li Y; McGeer A
    Infect Control Hosp Epidemiol; 2000 Nov; 21(11):700-4. PubMed ID: 11089653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-influenza respiratory viruses may overlap and obscure influenza activity.
    Drinka PJ; Gravenstein S; Krause P; Langer EH; Barthels L; Dissing M; Shult P; Schilling M
    J Am Geriatr Soc; 1999 Sep; 47(9):1087-93. PubMed ID: 10484251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An outbreak of influenza in four nursing homes in Sheffield.
    Commun Dis Rep CDR Wkly; 1998 Apr; 8(16):139. PubMed ID: 9599917
    [No Abstract]   [Full Text] [Related]  

  • 11. Emergence of rimantadine-resistant virus within 6 days of starting rimantadine prophylaxis with oseltamivir treatment of symptomatic cases.
    Drinka PJ; Haupt T
    J Am Geriatr Soc; 2007 Jun; 55(6):923-6. PubMed ID: 17537095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use.
    Houck P; Hemphill M; LaCroix S; Hirsh D; Cox N
    Arch Intern Med; 1995 Mar; 155(5):533-7. PubMed ID: 7864709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and control of influenza outbreaks in well-vaccinated nursing home populations.
    Monto AS; Rotthoff J; Teich E; Herlocher ML; Truscon R; Yen HL; Elias S; Ohmit SE
    Clin Infect Dis; 2004 Aug; 39(4):459-64. PubMed ID: 15356805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral prophylaxis in the management of an influenza outbreak in an aged care facility.
    Bush KA; McAnulty J; McPhie K; Reynolds R; Boomer M; Clarkson LM; Quaine J; Dwyer DE;
    Commun Dis Intell Q Rep; 2004; 28(3):396-400. PubMed ID: 15574064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with oseltamivir in the control of a nursing home influenza B outbreak.
    Parker R; Loewen N; Skowronski D
    Can Commun Dis Rep; 2001 Mar; 27(5):37-40. PubMed ID: 11260987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of long-term use of rimantadine for prophylaxis of type A influenza in nursing homes.
    Monto AS; Ohmit SE; Hornbuckle K; Pearce CL
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2224-8. PubMed ID: 8619572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality following isolation of various respiratory viruses in nursing home residents.
    Drinka PJ; Gravenstein S; Langer E; Krause P; Shult P
    Infect Control Hosp Epidemiol; 1999 Dec; 20(12):812-5. PubMed ID: 10614604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled zanamivir versus rimantadine for the control of influenza in a highly vaccinated long-term care population.
    Gravenstein S; Drinka P; Osterweil D; Schilling M; Krause P; Elliott M; Shult P; Ambrozaitis A; Kandel R; Binder E; Hammond J; McElhaney J; Flack N; Daly J; Keene O
    J Am Med Dir Assoc; 2005; 6(6):359-66. PubMed ID: 16286056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observations on managing an outbreak of influenza A infection in an aged care facility.
    McCall BJ; Mohr CM; Jarvinen KA
    Commun Dis Intell Q Rep; 2007 Dec; 31(4):410-2. PubMed ID: 18268884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with the rapid Directigen test for influenza.
    Drinka PJ
    J Am Med Dir Assoc; 2006 Jan; 7(1):37-9. PubMed ID: 16413433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.